In breast cancer, Stain et al. reported that silencing ERRα resulted in a decrease in the growth of xenograft tumor in vivo, although it had no effect on the proliferation of estrogen-independent cells in vitro [35]. The gene discussed is ESRRA; the disease is neoplasm.